Support women in science at Burnet Institute
Donate today to support women in science at Burnet and their work to unlock the vaginal microbiome and reduce risk of HIV infection and preterm birth for women around the world.
Immune Disease and Cancer, 2022 (4)
August, 2022 (1)
- Lenvatinib for the treatment of hepatocellular carcinoma-a real-world multicenter Australian cohort study.
Patwala K, Prince DS, Celermajer Y, Alam W, Paul E, Strasser SI, McCaughan GW, Gow P, Sood S, Murphy E, Roberts S, Freeman E, Stratton E, Davison SA, Levy MT, Clark-Dickson M, Nguyen V, Bell S, Nicoll A, Bloom A, Lee AU, Ryan M, Howell J, Valaydon Z, Mack A, Liu K, Dev A
Hepatol Int. 2022 Aug; 16(5):1170-1178
May, 2022 (1)
- Two-Dimensional and Three-Dimensional Time-of-Flight Secondary Ion Mass Spectrometry Image Feature Extraction Using a Spatially Aware Convolutional Autoencoder.
Gardner W, Winkler DA, Cutts SM, Torney SA, Pietersz GA, Muir BW, Pigram PJ
Anal Chem. 2022 May; 94(22):1804-1813
March, 2022 (1)
- Integrating HPV vaccination programs with enhanced cervical cancer screening and treatment, a systematic review.
Wirtz C, Mohamed Y, Engel D, Sidibe A, Holloway M, Bloem P, Kumar S, Brotherton J, Reis V, Morgan C
Vaccine. 2022 Mar; 40(Suppl 1):A116-A123
February, 2022 (1)
- A Quantitative Approach to Unravel the Role of Host Genetics in IgG-FcgammaR Complex Formation After Vaccination.
Lemke MM, Theisen RM, Bozich ER, McLean MR, Lee CY, Lopez E, Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kratochvil S, Wines BD, Hogarth PM, Kent SJ, Chung AW, Arnold KBKelly B Arnold
Front Immunol. 2022 Feb; 13:820148
Year
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
- 2013
- 2012
- 2011
- 2010
- 2009
- 2008
- 2007
- 2006
- 2005
- 2004
- 2003
- 2002
- 2001
- 2000
- 1999
- 1998
- 1997
- 1996
- 1995
- 1994
- 1993
- 1992
- 1991
- 1990
- 1989
- 1988
- 1987
- 1982
- 1981
- 1955
Program
- All
- Executive (0)
- Healthy Mothers, Healthy Babies (HMHB) (2)
- Towards Eliminating HIV (20)
- Strategic Funding & Partnerships Executive Team (0)
- Disease Elimination (265)
- Maternal, Child and Adolescent Health (202)
- Philanthropy and Supporter Engagement (0)
- Health Security and Pandemic Preparedness (105)
- Eliminate Malaria (42)
- Eliminate Tuberculosis (TB) (15)
- Finance (0)
- Healthy Ageing (1)
- Human Resources (0)
- Burnet Honorary Research Fellows (8)
- Research Support and Facilities (0)
- Harm Reduction (8)
- Information Technology (0)
- Burnet Vaccine Initiative (0)
- Laboratory Services (0)
- Eliminate Viral Hepatitis (37)
- Education & Training (0)
- Infectious Diseases Elimination (2)
- Support Services Group (0)
- Project Management and Quality Assurance Office (0)
- Marketing and Communications (0)
- International Operations (1)
- Commercialisation, Innovation and Industry Partnerships (0)
Discipline
- All
- Life Sciences (0)
- Public Health (0)
- International Development (0)
Research Theme
- All
- HIV and AIDS (27)
- Sexually Transmitted Infections (STIs) (8)
- Maternal and Child Health (62)
- Malaria (47)
- Immune Disease and Cancer (4)
- Hepatitis B (17)
- Hepatitis C (30)
- Global infectious disease threats (7)
- Injecting Drug Use (36)
- Alcohol and Other Drugs (38)
- Tuberculosis (TB) (15)
- Young People's Health (9)
- Justice Health (11)
- Nutrition (3)
- Sexual and Reproductive Health (12)
- Infectious Disease Modelling (15)
- Infectious Diseases Surveillance (2)
- LGBTQIA+ (6)
- Influenza (1)
- Global Adolescent Health (9)
- COVID-19 (novel coronavirus) (50)
